New Strategies for the Femoropopliteal Artery

Courtesy of Dr. Carlos Fava.

The incidence of peripheral vascular disease is clearly increasing, progressing towards critical ischemic claudication and amputation. Angioplasty is currently the treatment of choice for these pathologies.

Nuevas estrategias en el territorio femoropoplíteo

Several times, an implanted stent ends up cracking due to extensive calcification, increasing the rate of restenosis and worsening critical ischemia.

 

Technological development on drug-eluting baloons (DEB) and directional atherectomy (DA) may improve outcomes.


Read also: Diabetics’ Silent Ischemia Myth Busted”.


This study randomized 102 patients. Among them, 48 underwent directional atherectomy + DEB (DA was performed using the SilverHawk or TurboHawk devices, and DEBs eluted paclitaxel), and 54 received DEB only. There were 19 patients who were not randomized (NR) due to excessive calcification. They underwent DA with TurboHawk and DEB.

 

The mean age was 69 years old (most patients were men); risk factors and comorbidities were similar in all arms.

 

Lesion lengths were longer in the DA + DEB group (112.3 ± 40.3 mm vs. 96.6 ± 40.9 mm; p = 0.05). In the not randomized group (118.7 ± 56.2 mm) there were no differences as regards the rate of obstruction.


Read also: It Is a Fact: Cerebral Protection in TAVR Has Proved to Reduce Stroke and Death”.


Technical success (≤30% residual stenosis) was 89.6% for the DA+DEB group vs. 64.2% for the DEB group (p = 0.004). In the NR group, the rate of success was 84.2%. Use of a filter for distal embolic protection (SpiderFX) was 84.2% in the DA+DEB group and 100% in the NR group.

 

Among the randomized patients, 16.7% of the DA+DEB patients received predilation, and so did 74.1% in the DEB-only group. In the NR group, this rate was 31.6%. Bail-out bare metal stenting was performed in 3.7% and postdilatation was performed in 6.3% vs. 33.3% (p = 0.001).

 

After a 1-year follow-up, there were no differences in angiographic stenosis in the treated vessel (DA+DEB 33.6% ± 17.7% vs. 36.4± 17.6%), clinically driven target-lesion revasculatization (7.3% vs. 8%), patency as assessed by Doppler echocardiography (84.6% vs. 81.3%; 68.8% for the NR group), and freedom from major events (89.3% vs. 90%).

 

Conclusion

DA+DEB treatment was effective and safe, but the study lacked statistical power to show significant differences between both methods of revascularization in a 1-year follow-up.

 

Editorial Comment

This is the first randomized prospective study comparing both strategies at a 1-year follow-up, showing the effectiveness and safety of its use.

 

While there were no differences, higher-scale and longer-follow-up studies are warranted.

 

Technological development is crucial for better results in this area.

 

Courtesy of Dr. Carlos Fava.

 

Original title: Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency. Twelve-Month Results of the DEDINITIVE AR Study.

Reference: Thomas Zeller, et al. Circ Cardiovasc Interv 2017;10:e004848.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....